{"filing":{"accession_number":"0001193125-26-267676","cik":"0001501796","ticker":"AURA","company_name":"Aura Biosciences, Inc.","form":"8-K","filing_date":"2026-06-11","report_date":null,"primary_document":"aura-20260611.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526267676/aura-20260611.htm"},"events":[{"id":5371,"run_id":4705,"accession_number":"0001193125-26-267676","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from Aura Biosciences' 2026 Annual Meeting of Stockholders held on June 11, 2026. The filing reports voting outcomes for two proposals: election of two Class II directors (David Johnson and Teresa Marie Bitetti) and ratification of Ernst \u0026 Young LLP as the independent auditor. The detailed vote tallies (votes for, against, withheld, and broker non-votes) are characteristic of Item 5.07 disclosures and are material to investors as they confirm governance decisions and auditor appointment.","company_name":"Aura Biosciences, Inc.","ticker":"AURA","filing_date":"2026-06-11","form":"8-K","submitted_at":null,"items":[{"id":6360,"accession_number":"0001193125-26-267676","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Aura Biosciences' 2026 Annual Meeting of Stockholders held on June 11, 2026. The filing reports voting outcomes for two proposals: election of two Class II directors (David Johnson and Teresa Marie Bitetti) and ratification of Ernst \u0026 Young LLP as the independent auditor. The detailed vote tallies (votes for, against, withheld, and broker non-votes) are characteristic of Item 5.07 disclosures and are material to investors as they confirm governance decisions and auditor appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:33:46.444506+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6360,"accession_number":"0001193125-26-267676","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Aura Biosciences' 2026 Annual Meeting of Stockholders held on June 11, 2026. The filing reports voting outcomes for two proposals: election of two Class II directors (David Johnson and Teresa Marie Bitetti) and ratification of Ernst \u0026 Young LLP as the independent auditor. The detailed vote tallies (votes for, against, withheld, and broker non-votes) are characteristic of Item 5.07 disclosures and are material to investors as they confirm governance decisions and auditor appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:33:46.444506+00:00","company_name":"Aura Biosciences, Inc.","ticker":"AURA","filing_date":"2026-06-11"}]}